Oral S-1 with cisplatin, radiotherapy appears safe, effective in advanced NSCLC

Patients with advanced non–small cell lung cancer treated with the oral fluoropyrimidine derivative S-1 in combination with cisplatin and concurrent radiotherapy demonstrated encouraging responses, according to results of a phase 2 study.

Healio